Literature DB >> 8041715

A circularly permuted recombinant interleukin 4 toxin with increased activity.

R J Kreitman1, R K Puri, I Pastan.   

Abstract

Fusion of ligands such as growth factors to other proteins often dramatically reduces the affinity of the ligand for its receptor. With recombinant DNA techniques, the attachment point between the two proteins has until now been restricted to either the amino or the carboxyl terminus of the ligand. However, binding may be greatly compromised if both ends are close to the site at which the ligand binds to its receptor. To construct a single-chain growth factor fusion protein with the connection at a new site on the growth factor, we constructed a DNA fragment encoding circularly permuted interleukin 4 (IL4), termed IL4(38-37). This was accomplished by placing a start codon before position 38, connecting codons 1 and 129 with a sequence encoding a peptide linker, and placing a stop codon after codon 37 of IL4. IL4(38-37) was fused via its new carboxyl terminus, Lys37, to a truncated form of Pseudomonas exotoxin. The purified circularly permuted IL4-toxin bound to the IL4 receptor with 10-fold higher affinity than an IL4-toxin in which the toxin was fused to the carboxyl terminus of IL4. Circular permuteins of growth factors can improve the effectiveness of recombinant fusion proteins, because the junction can be moved to a site on the growth factor which allows it to bind with higher affinity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041715      PMCID: PMC44303          DOI: 10.1073/pnas.91.15.6889

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  40 in total

1.  A simple and efficient system for the construction of phoA gene fusions in gram-negative bacteria.

Authors:  A M Duchêne; J Patte; C Gutierrez; M Chandler
Journal:  Gene       Date:  1992-05-01       Impact factor: 3.688

2.  Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy.

Authors:  R Powers; D S Garrett; C J March; E A Frieden; A M Gronenborn; G M Clore
Journal:  Science       Date:  1992-06-19       Impact factor: 47.728

3.  A fully active variant of dihydrofolate reductase with a circularly permuted sequence.

Authors:  A Buchwalder; H Szadkowski; K Kirschner
Journal:  Biochemistry       Date:  1992-02-18       Impact factor: 3.162

4.  Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein.

Authors:  B M Curtis; D E Williams; H E Broxmeyer; J Dunn; T Farrah; E Jeffery; W Clevenger; P deRoos; U Martin; D Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

5.  Diphtheria toxin receptor-binding domain substitution with interleukin 6: genetic construction and interleukin 6 receptor-specific action of a diphtheria toxin-related interleukin 6 fusion protein.

Authors:  L F Jean; J R Murphy
Journal:  Protein Eng       Date:  1991-12

6.  Amino and carboxy-terminal regions in globular proteins.

Authors:  J M Thornton; B L Sibanda
Journal:  J Mol Biol       Date:  1983-06-25       Impact factor: 5.469

7.  Genetic construction and characterization of a fusion protein consisting of a chimeric F(ab') with specificity for carcinomas and human IL-2.

Authors:  H P Fell; M A Gayle; L Grosmaire; J A Ledbetter
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

8.  Selective proteolytic cleavage of recombinant human interleukin 4. Evidence for a critical role of the C-terminus.

Authors:  H V Le; G F Seelig; R Syto; L Ramanathan; W T Windsor; D Borkowski; P P Trotta
Journal:  Biochemistry       Date:  1991-10-08       Impact factor: 3.162

9.  Circular and circularly permuted forms of bovine pancreatic trypsin inhibitor.

Authors:  D P Goldenberg; T E Creighton
Journal:  J Mol Biol       Date:  1983-04-05       Impact factor: 5.469

10.  Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections.

Authors:  U Brinkmann; J Buchner; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 12.779

View more
  20 in total

1.  In vivo assembly of aspartate transcarbamoylase from fragmented and circularly permuted catalytic polypeptide chains.

Authors:  X Ni; H K Schachman
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

Review 2.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

3.  Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.

Authors:  S R Husain; P Gill; R J Kreitman; I Pastan; R K Puri
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

4.  Random circular permutation of genes and expressed polypeptide chains: application of the method to the catalytic chains of aspartate transcarbamoylase.

Authors:  R Graf; H K Schachman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  Circular permutation within the coenzyme binding domain of the tetrameric glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus.

Authors:  M L Vignais; C Corbier; G Mulliert; C Branlant; G Branlant
Journal:  Protein Sci       Date:  1995-05       Impact factor: 6.725

Review 6.  New delivery approaches for pediatric brain tumors.

Authors:  Ian F Pollack; Robert Keating
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

7.  Clinical development of experimental therapies for malignant glioma.

Authors:  Nikolai G Rainov; Volkmar Heidecke
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

8.  In vivo formation of allosteric aspartate transcarbamoylase containing circularly permuted catalytic polypeptide chains: implications for protein folding and assembly.

Authors:  P Zhang; H K Schachman
Journal:  Protein Sci       Date:  1996-07       Impact factor: 6.725

9.  A novel reduced immunogenicity bispecific targeted toxin simultaneously recognizing human epidermal growth factor and interleukin-4 receptors in a mouse model of metastatic breast carcinoma.

Authors:  Seunguk Oh; Brad J Stish; Deepali Sachdev; Hua Chen; Arkadiusz Z Dudek; Daniel A Vallera
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

10.  Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity.

Authors:  B J Stish; S Oh; H Chen; A Z Dudek; R A Kratzke; D A Vallera
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 9.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.